☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
Astrazeneca
AstraZeneca’s Tagrisso Plus Chemotherapy Receives the EC’s Approval to Treat EGFR-Mutated Advanced Lung Cancer
July 5, 2024
AstraZeneca at ATS’24: Andrew Menzies-Gow from AstraZeneca in a Stimulating Conversation with PharmaShots
July 3, 2024
AstraZeneca’s Lynparza Plus Imfinzi Receives the CHMP’s Positive Opinion for Treating Endometrial Cancer
July 2, 2024
AstraZeneca Reports the EMA’s Acceptance of MAA for Sipavibart Under Accelerated Assessment to Prevent COVID-19
July 1, 2024
AstraZeneca’s Tagrisso Plus Chemotherapy Receives NMPA’s Approval to Treat EGFR-Mutated Advanced Lung Cancer
June 27, 2024
AstraZeneca’s Tagrisso Plus Chemotherapy Receives Japanese Approval to Treat EGFR-Mutated Advanced Lung Cancer
June 26, 2024
Load more...
Back to Home